The world has finally reached "the beginning of the end" of the AIDS pandemic that has killed millions in the past three decades.
But in a report to mark World AIDS Day on December 1, the
ONE campaign, an advocacy group working to end poverty and preventable disease
in African countries, reminds that, "The tipping point in fight against disease
globally has been reached but still more to do."
"We've passed the tipping point in the AIDS fight at the global level,
but not all countries are there yet, and the gains made can easily stall or
unravel," Erin Hohlfelder, ONE's director of global health policy, said.
AIDS/HIV - Common Opportunistic Infections
Kaposi sarcoma develops below the skin surfaces or in mucous membranes of mouth, nose or anus and appears as lumps
Advertisement
The HIV that causes AIDS is spread via blood, semen and breast milk. There is no cure for the infection, but it can be kept at bay with cocktails of antiretroviral drugs.
The AIDS pandemic began more than three decades ago and has killed up to 40
million people worldwide.
The United Nations AIDS agency says that, by June 2014, around 14 million people globally had access to AIDS drugs, a drastic improvement on the 5 million who were getting treatment in 2010.
![AIDS-HIV-Cancer]( "AIDS-HIV-Cancer")
AIDS defining malignancies are cancers that occur in patients with AIDS due to their low immunity.
"Despite the good news, we should not take a victory lap yet," said Hohlfelder.
She pointed out several threats to current progress, including a $3 billion shortfall in the funds needed each year to control HIV around the world.
"We need funding from a more diversified base, including more from African domestic budgets," she said.
ONE campaign also noted that HIV is increasingly concentrated among hard-to-reach communities such as injecting drug users, sex workers and gay men - groups who are often stigmatised and have trouble accessing prevention services and treatment.
Source: Medindia
The United Nations AIDS agency says that, by June 2014, around 14 million people globally had access to AIDS drugs, a drastic improvement on the 5 million who were getting treatment in 2010.
AIDS-HIV-Cancer
AIDS defining malignancies are cancers that occur in patients with AIDS due to their low immunity.
Advertisement
"Despite the good news, we should not take a victory lap yet," said Hohlfelder.
She pointed out several threats to current progress, including a $3 billion shortfall in the funds needed each year to control HIV around the world.
"We need funding from a more diversified base, including more from African domestic budgets," she said.
ONE campaign also noted that HIV is increasingly concentrated among hard-to-reach communities such as injecting drug users, sex workers and gay men - groups who are often stigmatised and have trouble accessing prevention services and treatment.
Source: Medindia
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV
Advertisement
 AIDS/HIV - Clinical FeaturesEncyclopedia section of medindia gives general info about HIV Clinical Features | Advertisement
|
Advertisement
Recommended Readings
Latest AIDS/HIV News
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
